New Delhi: The Central Drugs Standard Control Organization (CDSCO) has issued a critical regulatory directive aimed at completely digitizing and streamlining the import and registration protocols for biological products in India.
In a circular issued by the Vaccine Division (Reference: F. No. VAC-11014(17)/4/2026-eoffice), Drugs Controller General (India) Dr. Rajeev Singh Raghuvanshi announced that all applications seeking approval for Post Approval Changes (PAC) in Registration Certificates (RC) and Import Licences for human vaccines and anti-sera must now be processed exclusively through the online SUGAM Portal.
The new mandate takes effect immediately, with a strict enforcement cut-off date.
Key Highlights of the CDSCO Mandate
1. Transition to Exclusive Online Submission
To standardize regulatory procedures and ensure greater transparency, the online submission system for post-approval variations has been made fully functional. Importers must now file all variations, quality modifications, or safe-and-efficacy updates directly via the SUGAM official website: www.cdscoonline.gov.in.
2. Strict Ban on Hard Copies & Emails
Effective July 1, 2026, the CDSCO will officially stop accepting physical or electronic mail applications.
- No Hard Copies: Submissions routed manually through the Central Receipt Unit (CRU) will be rejected.
- No Email Submissions: Scanned or emailed requests sent directly to the division or regulatory desks will no longer be accepted for processing.
3. Specific Module Allocation
Importers must navigate to the specific “Other Section Checklist Module of Post Approval Changes” within the SUGAM portal interface to deposit their filings.
4. Compliance with Guidance Documents
Every filed change must strictly align with the checklists and parameters prescribed under the current CDSCO guidelines:
- Reference Guideline: “CDSCO Guidance for Industry – Post Approval Changes in Biological Products: Quality, Safety and Efficacy Documents”
- Applicable Protocol: Document No. PAC/2024 Version – 1.2.
Step-by-Step Action Plan for Importers
For uninterrupted logistical and supply chain clearance of human vaccines and anti-sera into the Indian market, authorized agents and importers should follow these steps immediately:
[Step 1: Portal Access ] Log into the SUGAM Online Portal (www.cdscoonline.gov.in) using verified corporate credentials. →
[ Step 2: Select Module ] Navigate to the “Other Section Checklist Module” designated specifically for Post Approval Changes. →
[ Step 3: Align Documentation ] Audit change records against CDSCO Document No. PAC/2024 Version-1.2 (Quality, Safety & Efficacy data). →
[ Step 4: Digital Upload & Track ] Upload files digitally, submit through the secure system, and track status parameters live on the portal dashboard.
Impact and Structural Benefits
The complete phase-out of manual handling is projected to eliminate delays in assessing vaccine and anti-sera modifications. By centralizing all post-licensing changes, the CDSCO aims to create a traceable, time-bound ecosystem that protects the integrity of imported biological products while accelerating the go-to-market timeline for critical public healthcare therapeutics.
Importers experiencing technical issues or requiring portal access validation are encouraged to contact the CDAC Technical Team or the CDSCO Vaccine Division at the earliest to prevent application backlogs.
